These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. [Physostigmine in treatment of cerebellar ataxia]. Aschoff JC; Kailer NA; Walter K Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510 [TBL] [Abstract][Full Text] [Related]
55. Influence of the route of administration on thyrotropin-releasing hormone concentration in the mouse brain. Mitsuma T; Nogimori T Experientia; 1983 Jun; 39(6):620-2. PubMed ID: 6406262 [No Abstract] [Full Text] [Related]
56. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease. Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461 [TBL] [Abstract][Full Text] [Related]
58. A cerebellar ataxic rat produced by kainic acid and changes in concentration and turnover rates of catecholamines in discrete brain regions. Niimi M; Takahara J; Aoki Y; Fujino H; Ofuji T Acta Med Okayama; 1982 Jun; 36(3):223-7. PubMed ID: 7113747 [TBL] [Abstract][Full Text] [Related]
59. Letter: Thyrotrophin-releasing hormone in depression. Mountjoy CQ; Hall R Lancet; 1974 Aug; 2(7877):415. PubMed ID: 4137018 [No Abstract] [Full Text] [Related]
60. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]